Explore the innovative concept of vibe coding and how it transforms drug discovery through natural language programming.

Rochester, Minn.-based Mayo Clinic and pharmaceutical giant Merck are teaming up to leverage AI for drug discovery and ...

Explore the impact of AI in drug discovery as 2026 promises critical clinical results and industry transformations.

We are glad that Isomorphic is helping advance the field and are able to match the level of performance we demonstrated at the ARDD conference in Copenhagen last August. In August, Deep Origin ...

After sharing word that it would be prioritizing artificial intelligence to aid discovery work, Takeda Pharmaceuticals has inked a multiyear deal to access Iambic Therapeutics' broad suite of& | ...

AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.

The Computational Analysis of Novel Drug Opportunities (CANDO) platform is a computational approach to make drug discovery faster and less expensive while also being safe and effective. According to ...

Over the past year, drug discovery has gotten a massive boost from the CAS BioFinder Discovery Platform, which allows scientists to explore known and predicted data that accelerate the preclinical ...

TOKYO--(BUSINESS WIRE)--Elix, Inc. (CEO: Shinya Yuki / Headquarters: Tokyo; hereinafter “Elix”) is pleased to announce that its AI drug discovery platform, Elix ...

New approach methodologies (NAMs) aim to address the limitations of animal models by assessing drug efficacy and safety in a more ethical, human-relevant way. The term ‘NAMs’ encompasses several ...